IHAM
Integral Health Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-420,000
| Closed | -$13.4M | – | 78 |
|
|
2024
Q4 | $13.4M | Buy |
+420,000
| New | +$13.4M | 1.14% | 31 |
|
|
2024
Q2 | – | Sell |
-150,000
| Closed | -$8.82M | – | 75 |
|
|
2024
Q1 | $8.82M | Buy |
+150,000
| New | +$8.82M | 0.82% | 45 |
|
|
2023
Q3 | – | Sell |
-72,000
| Closed | -$6.56M | – | 66 |
|
|
2023
Q2 | $6.56M | Buy |
+72,000
| New | +$6.56M | 0.81% | 46 |
|
|
2022
Q4 | – | Sell |
-70,000
| Closed | -$4.78M | – | 63 |
|
|
2022
Q3 | $4.78M | Sell |
70,000
-29,150
| -29% | -$1.99M | 0.93% | 42 |
|
|
2022
Q2 | $4.48M | Buy |
99,150
+59,381
| +149% | +$2.69M | 0.92% | 36 |
|
|
2022
Q1 | $2.02M | Sell |
39,769
-80,231
| -67% | -$4.08M | 0.53% | 56 |
|
|
2021
Q4 | $5.67M | Sell |
120,000
-70,000
| -37% | -$3.31M | 1.57% | 27 |
|
|
2021
Q3 | $6.26M | Buy |
190,000
+155,000
| +443% | +$5.11M | 1.8% | 18 |
|
|
2021
Q2 | $2.21M | Buy |
+35,000
| New | +$2.21M | 0.61% | 47 |
|
|
2020
Q4 | – | Sell |
-90,000
| Closed | -$2.72M | – | 58 |
|
|
2020
Q3 | $2.72M | Buy |
+90,000
| New | +$2.72M | 0.83% | 43 |
|
|
2020
Q1 | – | Sell |
-35,000
| Closed | -$1.07M | – | 54 |
|
|
2019
Q4 | $1.07M | Buy |
+35,000
| New | +$1.07M | 0.42% | 48 |
|